Literature DB >> 86375

Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.

C J Smith, P C Kelleher, L Bélanger, L Dallaire.   

Abstract

Alpha-fetoprotein (AFP) concanavallin-A-affinity molecular variant patterns were determined in amniotic fluid samples from 10 pregnancies complicated by anencephaly (6), spina bifida (1), Turner's syndrome (1), osteogenesis imperfecta congenita (1), and fetal death (1) and 20 normal pregnancies between 14.6 and 25.5 weeks of gestation. With the exception of one anencephalic pregnancy, the AFP concentrations in samples from women with a fetal abnormality were more than 5 SD above normal for gestational age. In every case, however, the proportion of total amniotic fluid AFP that was not reactive with concanavallin A was significantly smaller in the presence of a fetal abnormality (mean 2%) than when the fetus was normal (mean 20%). The results suggest that measuring the amount of concanavallin-A-non-reactive amniotic fluid AFP will be a valuable test for diagnosing fetal abnormality, especially when an increase in total amniotic fluid AFP concentration is equivocal or gestational age is uncertain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86375      PMCID: PMC1598569          DOI: 10.1136/bmj.1.6168.920

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida.

Authors:  D J Brock; R G Sutcliffe
Journal:  Lancet       Date:  1972-07-29       Impact factor: 79.321

3.  Amniotic fluid AFP in multiple pregnancy.

Authors:  M J Seller; J E Dumon; J S Vanderheyden
Journal:  Br Med J       Date:  1977-06-18

4.  Mechanisms by which amniotic-fluid alpha-fetoprotein may be increased in fetal abnormalities.

Authors:  D J Brock
Journal:  Lancet       Date:  1976-08-14       Impact factor: 79.321

Review 5.  Prenatal diagnosis - chemical methods.

Authors:  D J Brock
Journal:  Br Med Bull       Date:  1976-01       Impact factor: 4.291

6.  Double-antibody enzyme immunoassay applied to human alpha 1-fetoprotein.

Authors:  L Belanger; D Hamel; D Dufour; M Pouliot
Journal:  Clin Chem       Date:  1976-02       Impact factor: 8.327

7.  Concanavalin A affinity molecular variants of alpha-fetoprotein in neonatal rat serum and in the serum of rats bearing hepatomas.

Authors:  C J Smith; H P Morris; P C Kelleher
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

8.  Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay.

Authors:  M E Kimball; A Milunsky; E Alpert
Journal:  Obstet Gynecol       Date:  1977-05       Impact factor: 7.661

9.  Alpha-fetoprotein and albumin in experimentally-induced exencephaly in the rat.

Authors:  C J Smith; P C Kelleher
Journal:  Teratology       Date:  1977-08
  9 in total
  5 in total

Review 1.  Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect.

Authors:  R Harris
Journal:  Br Med J       Date:  1980-05-17

Review 2.  Prenatal diagnosis of common genetic disorders.

Authors:  M D Crawfurd
Journal:  BMJ       Date:  1988 Aug 20-27

Review 3.  Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.

Authors:  Y Aoyagi
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

Review 4.  Neural tube defects: from a proteomic standpoint.

Authors:  Tania M Puvirajesinghe; Jean-Paul Borg
Journal:  Metabolites       Date:  2015-03-17

5.  Close topographical relationship in alpha foetoprotein (AFP) between a lens culinaris binding glycan and the epitope recognized by AFP-reactive monoclonal antibody, 18H4.

Authors:  Y Suzuki; Y Aoyagi; M Muramatsu; C Sekine; M Isemura; F Ichida
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.